Dec 16, 2025
What’s Going On With Ford Stock?

Shares of Ford Motor Company (NASDAQ:F) are trending Tuesday after the company announced an adjustment of its electric vehicle strategy and introduced a new battery energy storage system business. Ford Motor stock is trading at elevated levels. What’s next for F…

Dec 16, 2025
Why Is Autozi Internet Stock Gaining Tuesday?

Autozi Internet Technology (Global) Ltd. (NASDAQ:AZI) stock rose Tuesday as investors reacted to a major procurement development. The automotive e-commerce company said it signed a large procurement-intention agreement with potential buyers. Autozi disclosed a memorandum covering procurement intentions totaling about…

Dec 16, 2025
What’s Going On With Rezolve AI Shares Tuesday?

Rezolve AI (NASDAQ:RZLV) shares are trading higher Tuesday after the company reported preliminary December revenue results. Rezolve AI shares are climbing with conviction. Why is RZLV stock surging? What To Know: Rezolve AI said December is expected to be the…

Dec 16, 2025
What’s Going On With uniQure Stock On Tuesday?

uniQure NV (NASDAQ:QURE) stock has plunged around 31% over the last month, as per data from Benzinga Pro. • uniQure stock is trading at depressed levels. Where are QURE shares going? UniQure stock reached as high as $22 on Tuesday…

Dec 16, 2025
Big Money Bets On Tesla Stock: Billionaire Bulls and Bears In Q3

While retail investors debated the headlines on Tesla, Inc. (NASDAQ:TSLA), the "smart money" was quietly picking sides during the third quarter.  TSLA stock is at all-time highs. See the chart and price action here.  The 13F filings for Q3 reveal…

Dec 16, 2025
Peruvian Cement Stock Cementos Pacasmayo Skyrockets After Holcim Move

Cementos Pacasmayo S.A.A. (NYSE:CPAC) stock skyrocketed Tuesday after the company announced a significant ownership change after a global cement leader agreed to acquire its controlling shareholder. Switzerland-based Holcim Ltd. (OTC:HCMLY) signed an agreement to purchase Inversiones Aspi S.A., part of…

Dec 16, 2025
Nektar Alopecia Trial Misses Endpoint, Hits Significance After Patient Exclusion

Nektar Therapeutics (NASDAQ:NKTR) on Tuesday revealed topline results from the 36-week induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin. The global Phase 2b study is being conducted in 92 patients with severe-to-very-severe alopecia areata. Alopecia areata…

Dec 16, 2025
Palantir Technologies: Analyst Expects AI Tailwinds To Support Growth Momentum

Meetings with Palantir Technologies Inc (NASDAQ:PLTR) increased confidence in the company's growth, and continued momentum along with enterprise-level AI adoption, according to BofA Securities. The Palantir Technologies Analyst: Analyst Mariana Perez Mora reiterated a Buy rating and a $255 price…